Global Oncology Business Strategy and Analytics Intern

Join a Legacy of Innovation 125 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.  

We are currently seeking a Global Oncology Business Strategy and Analytics Intern from for Summer 2026. This full-time positions works approximately 37.5 hours per week.

Responsibilities:

The Intern will support Strategic Planning initiatives within the Oncology Business Unit related to Investor Relations Events, R&D Pipeline Prioritization, and working on Long Term Portfolio Forecasts.

Qualifications:

Bachelor’s degree either Science or Business at a minimum and also be proficient in Microsoft Excel and PowerPoint. Previous experience in the Pharmaceutical Industry is a Plus.

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer.  All qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.  

Salary Range: